Market cap
$24.093 B
$118.20 -3.79%
Close of 6 Nov 2026
As of 6 Nov 2026, Incyte (INCY) has a market capitalization of $24.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$5.14B
#654 by revenue
Earnings
$1.29B
#323 by earnings
Shares outstanding
203,832,492
Latest filing cover page
P/E ratio
18.7
Cap ÷ net income
Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap
All 12 →- #1IqviaIQV$43.6B
- #2IncyteINCY$24.1B
- #3MedpaceMEDP$17.7B
- #4IconICLR$15.4B
- #5Charles River Laboratories InternationalCRL$15.0B
What if Incyte were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Incyte are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.